Loading...
Imunon, Inc.
CLSN•NASDAQ
Healthcare
Biotechnology
$1.95
$-0.01(-0.68%)
Imunon, Inc. (CLSN) Financial Performance & Income Statement Overview
Review Imunon, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-90875.06%
↓ 90875.06%
Net Income Growth
-95315.14%
↓ 95315.14%
Operating Cash Flow Growth
-99021.14%
↓ 99021.14%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-428.00%
↓ 428.00%
ROIC
-1714.83%
↓ 1714.83%
Imunon, Inc. (CLSN) Income Statement & Financial Overview
Review Imunon, Inc.'s (CLSN) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $2.87M | $5.87M | $10.31M | $5.31M |
| Short Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Cash & Short Term Investments | $2.87M | $5.87M | $10.31M | $5.31M |
| Net Receivables | $0.00 | $0.00 | $0.00 | $0.00 |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Assets | $2.22M | $2.14M | $2.22M | $2.34M |
| Total Current Assets | $5.09M | $8.009M | $12.53M | $7.65M |
| Property Plant & Equipment (Net) | $1.72M | $1.66M | $1.81M | $2.00M |
| Goodwill | $0.00 | $0.00 | $0.00 | $0.00 |
| Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill & Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Long Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Tax Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Assets | $50000.00 | $50000.00 | $50000.00 | $50000.00 |
| Total Non-Current Assets | $1.77M | $1.71M | $1.86M | $2.05M |
| Total Assets | $6.86M | $9.72M | $14.39M | $9.69M |
| Account Payables | $1.86M | $1.30M | $2.36M | $1.97M |
| Short Term Debt | $394878.00 | $452358.00 | $508450.00 | $516223.00 |
| Tax Payables | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Liabilities | $3.54M | $3.03M | $2.57M | $2.59M |
| Total Current Liabilities | $5.80M | $4.79M | $5.44M | $5.08M |
| Long Term Debt | $613171.00 | $686935.00 | $757726.00 | $872910.00 |
| Deferred Revenue Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Tax Liabilities Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Liabilities | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Non-Current Liabilities | $613171.00 | $686935.00 | $757726.00 | $872910.00 |
| Capital Lease Obligations | $1.008B | $1.14M | $1.27M | $872910.00 |
| Total Liabilities | $6.41M | $5.47M | $6.20M | $5.95M |
| Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock | $146207.00 | $145007.00 | $145007.00 | $94009.00 |
| Retained Earnings | -$410.91M | -$406.80M | -$402.75M | -$397.90M |
| Accumulated Other Comprehensive Income/Loss | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Stockholders Equity | $452028.00 | $4.24M | $8.19M | $3.74M |
| Total Equity | $452028.00 | $4.24M | $8.19M | $3.74M |
| Total Liabilities & Stockholders Equity | $6.86M | $9.72M | $14.39M | $9.69M |
| Total Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Debt | $1.008M | $1.14M | $1.27M | $1.39M |
| Net Debt | -$1.86M | -$4.73M | -$9.05M | -$3.92M |
Imunon, Inc. (CLSN) Balance Sheet Analysis
Imunon, Inc. (CLSN) manages its money wisely, with plenty of -99021.14% and -95315.14% to cover its bills. The company’s long-term debts are N/A, balanced by steady 0.00%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a stable position, giving it room to invest, expand, or adapt. For investors, this paints a steady picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan